13F Holdings
中文EN

IOSP INNOSPEC INC.

Chemicals & Allied Products · Nasdaq · SEC CIK 1054905 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.7%
TTM net income YoY2,749.1%
TTM EPS YoY14,250.0%
Revenue 3-yr CAGR-1.6%
Net income 3-yr CAGR3.4%

Margins

Gross margin27.7%
Operating margin8.8%
Net margin7.5%
FCF margin2.5%
EBITDA margin10.9%

Returns

ROE10.5%
ROA7.7%
ROIC (approx.)12.4%
Asset turnover1.03x

Leverage & solvency

Liabilities / assets25.7%
Debt / equity0.00x
Current ratio2.95x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.74x
Accruals ratio2.0%
Payout ratio—
Capex / revenue3.0%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY2025*2025-12-31FY2024*2024-12-31FY2023*2023-12-31FY2022*2022-12-31FY2021*2021-12-31
Income statement
Revenue$1.78B$1.85B$1.95B$1.96B$1.48B
Cost of revenue$1.29B$1.30B$1.36B$1.38B$1.05B
Gross profit$492.40M$542.90M$591.10M$586.70M$434.90M
R&D expense$51.00M$56.50M$49.00M$38.70M$37.40M
SG&A expense$285.10M$305.30M$380.50M$360.70M$267.20M
Operating income$129.50M$177.90M$161.60M$187.30M$132.10M
Interest expense$0$0$0$0$0
Pretax income$138.10M$41.20M$174.40M$184.60M$134.40M
Income tax$21.50M$5.60M$35.30M$51.60M$41.30M
Net income$116.60M$33.20M$139.00M$133.00M$93.00M
EBITDA$173.10M$221.40M$200.90M$227.40M$174.80M
EPS (basic)4.691.435.605.373.78
EPS (diluted)4.671.425.565.323.75
Dividends declared per share1.711.551.411.281.16
Weighted avg. shares (diluted)24.99M25.12M25.02M24.98M24.85M
Balance sheet
Cash & equivalents$292.50M$289.20M$203.70M$147.10M$141.80M
Receivables$342.30M$341.70M$359.80M$334.60M$284.50M
Inventory$329.30M$301.00M$300.10M$373.10M$277.60M
Current assets$1.00B$956.60M$885.70M$872.60M$728.10M
PP&E, net$286.10M$269.70M$268.30M$220.90M$214.40M
Goodwill$399.00M$382.50M$399.30M$358.80M$364.30M
Intangibles$67.70M$65.40M$57.30M$45.00M$57.50M
Total assets$1.83B$1.73B$1.71B$1.60B$1.57B
Current liabilities$360.10M$371.40M$371.50M$405.80M$336.60M
Total liabilities$499.50M$518.60M$557.80M$563.30M$537.90M
Shareholders' equity$1.33B$1.21B$1.15B$1.04B$1.03B
Cash flow statement
Operating cash flow$138.30M$184.50M$207.30M$81.70M$93.20M
Capital expenditure$50.30M$41.40M$62.10M$39.60M$39.10M
Free cash flow$88.00M$143.10M$145.20M$42.10M$54.10M
Investing cash flow-$75.10M-$62.00M-$111.80M-$42.10M-$36.20M
Financing cash flow-$63.90M-$35.30M-$39.00M-$33.70M-$20.00M
Depreciation & amortization$43.60M$43.50M$39.30M$40.10M$42.70M
Stock-based compensation$8.10M$8.50M$8.00M$6.70M$4.40M
Dividends paid$42.40M$38.80M$35.10M$31.70M$28.80M
Share buybacks$23.90M$700,000$1.10M$5.90M$800,000

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.